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Background: Acute kidney injury (AKI) is one of the major morbidities after surgical repair of abdominal aortic
aneurysm (AAA); however, precise pathogenesis of this morbidity has not been well determined. Since prothrombotic
coagulation abnormality may precede organ dysfunction in systemic inflammatory state, we examined the kinetics of
von Willebrand factor (VWF) and a disintegrin-like metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13),
a cleaving enzyme of VWF, on the development of AKI after AAA surgery.
Methods: The kinetics of ADAMTS13 and VWF were examined in ten patients who underwent surgical repair of AAA.
The changes in plasma neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker for AKI, and serum
creatinine concentration were also examined at four points until seventh postoperative day (POD). Clinical
diagnosis of AKI was based on the change in serum creatinine concentration and urine output according to
Acute Kidney Injury Network (AKIN) criteria.
Results: ADAMTS13 activity was significantly lower than normal level before the surgery and showed a trend of
decrease toward 3POD. The VWF/ADAMTS13 ratio showed a significant increase on 1POD, which persisted until
7POD. None of patents was diagnosed as AKI based on AKIN criteria, although two patients received furosemide
and/or carperitide therapy because of decreased urine output less than 0.5 ml/kg/h for several hours in ICU.
Plasma NGAL showed a trend to increase after the surgery, which was significant on 3POD. The change in
plasma NGAL was significantly correlated with VWF/ADAMTS13 ratio (P < 0.01).
Conclusions: This study has shown that patients undergoing AAA surgery were prothrombotic after the surgery
because of high VWF/ADAMTS13 ratio. Correlation between VWF/ADAMTS13 ratio and NGAL might indicate
contribution of thrombotic event to subclinical AKI in the patients undergoing AAA surgery.
Keywords: ADAMTS13, Acute kidney injury, AKI, Neutrophil gelatinase-associated lipocalin, NGAL, Abdominal
aortic aneurysmBackground
Acute kidney injury (AKI) is one of the major morbidities
after surgical repair of abdominal aortic aneurysm (AAA).
The incidence of AKI after AAA surgery, although it
depends on the definition of AKI, varies between 22% and
75%, which is extremely high in ruptured AAA [1-3]. The* Correspondence: nbyk@a5.keio.jp
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reproduction in any medium, provided the ormechanisms to develop perioperative AKI include ath-
erosclerosis of renal artery, renal ischemia-reperfusion
injury due to aortic cross-clamp, circulatory failure,
and nephrotoxic agents as well as the neuroendocrine
and inflammatory stress response to the surgery [4-6].
Recent investigations indicated that deterioration of
the balance between von Willebrand factor (VWF) and its
cleaving protease was associated with organ dysfunction in-
cluding AKI in critically ill patients [7,8]. Von WillebrandLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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hesion and aggregation at the vascular injury site, is
synthesized in endothelial cells and megakaryocytes
and is released into the blood stream by stimulation of
inflammatory mediators such as interleukins or tumor
necrosis factor α [9]. VWF is released from endothelial
cells in the form of unusually large VWF multimer
(UL-VWF) which can induce abnormal platelet aggre-
gation and thrombus formation [10]. This abnormal
thrombus formation due to UL-VWF could cause throm-
botic microangiopathy (TMA), which results in organ
dysfunction. But thrombogenic potential of UL-VWF is
usually regulated by a protease secreted from hepatic
stellate [10], named ADAMTS13 (a disintegrin-like
metalloprotease with thrombospondin type 1 motif 13).
ADAMTS13 cleaves UL-VWF into smaller multimers and
reduces agglutinative properties of UL-VWF. Hence, the
decrease in ADAMTS13 activity is related to the increase
in circulating UL-VWF and plasma VWF antigen level,
which may contribute to organ dysfunction subsequent to
TMA [11,12]. As ADAMTS13 activity is attenuated by
systemic inflammation [12], decrease in ADAMTS13 ac-
tivity induced by inflammatory cytokines in major aortic
surgery could contribute to the development of postopera-
tive organ dysfunction including AKI.
Few studies to date, however, have examined the change
in ADAMTS13 activity in AAA surgery or the contribu-
tion of the balance between ADAMTS13 and VWF to
development of prothrombotic coagulation abnormalities.
Hence, we conducted a prospective observational study to
investigate perioperative change in ADAMTS13 activity
and also a relationship between prothrombotic property in-
dicated as VWF antigen/ADAMTS13 activity ratio and the
development of AKI in patients undergoing AAA surgery.
Methods
Patients
With approval of Institutional Review Board of Keio
University Hospital (Tokyo, Japan) and written informed
consents, adult patients undergoing elective open infra-
renal abdominal aortic surgery were included in the study.
The exclusion criteria for the study were preexisting renal
failure requiring hemodialysis and/or preoperative serum
creatinine concentration (Cr) ≥2 mg/dl, active hepatitis or
cirrhosis, and hemostatic disorder. Postoperative AKI was
defined by AKIN criteria: the Cr increased by more than
0.3 mg/dl compared with the preoperative value; the per-
cent increase in Cr was more than 50% compared with
the preoperative value; urine output less than 0.5 ml/kg/h
continued for more than 6 h [13].
Anesthesia management
After the placement of an epidural catheter at Th7/8 or
8/9 level, general anesthesia was induced with propofoland rocuronium, and the trachea was intubated. Anesthesia
was maintained with sevoflurane (1.5%−2.5%) in 40%−60%
oxygen and thoracic epidural analgesia. Mechanical ventila-
tion was performed to maintain arterial carbon dioxide
pressure between 30 and 40 mmHg. All patients received
a radial arterial catheter with FloTrac™ sensor (Edwards
Lifesciences, CA, USA) and PreSep™ oximetry catheter
(Edwards Lifesciences, CA, USA) via internal jugular
vein as hemodynamic monitors in conjunction with
routine monitors including electrocardiogram and pulse
oximeter. Fluid therapy was managed with the infusions
of crystalloid and hydroxyethyl starch, guided by mean
arterial blood pressure, cardiac output, and central ven-
ous pressure, and central venous oxygen saturation.
Erythrocyte salvage device (Cell Saver®, Haemonetics
Japan GK, Tokyo, Japan) was applied in all cases to
salvage red blood cells during the surgery. Transfusion
of blood products including irradiated packed red blood
cells (RBC), fresh frozen plasma (FFP), or platelet concen-
trate (PC) was decided by attending anesthesiologists
according to the results of complete blood count or co-
agulation tests. Vasoactive agents including phenyleph-
rine or ephedrine were administered intermittently to
maintain mean arterial blood pressure more than 60
mmHg to obviate the risk of perioperative AKI [3].
Routine use of diuretic agents including furosemide,
low-dose dopamine, or carperitide was avoided, whereas
all patients received the infusion of 1 g/kg D-mannitol
before aortic cross-clamp as an institutional protocol.
All patients received 100 unit/kg of unfractionated
heparin as a primary dose for anticoagulation during
aortic cross-clamp. After the confirmation that celite-
activated clotting time (ACT) reached more than 250
s, the infrarenal aorta was cross-clamped. ACT was
monitored every 30 min and additional heparin was
administered to maintain ACT between 200 and 300 s
if needed until all vascular anastomosis was finished.
Minimum required dose of protamine was administered if
ACT was prolonged more than 200 s after the reperfusion.
The trachea was extubated in all patients in the operation
room, and they were transferred to the ICU.
Sample collection
Twenty milliliters of blood was collected from the patients
at the following four time points: (1) preoperative, (2) the
first postoperative day (1POD), (3) 3POD, and (4) 7POD.
Twelve milliliters of the blood was immediately sent to
the laboratory for complete blood count, Cr, and coagu-
lation tests as a routine clinical examination in AAA
surgery. Eight milliliters of the blood was collected into
citrate tubes and immediately centrifuged at 1,500×g for
10 min, and the plasma was stored at −80°C for the
assays of ADAMTS13 activity, VWF antigen, cytokines,
and neutrophil gelatinase-associated lipocalin (NGAL).
Table 1 Patient characteristics
Patient characteristics Values
Gender (male/female) 8/2
Age (years) 71 ± 10
Height (cm) 164 ± 9




Atrial fibrillation 2 (20%)
sCr ≥ 1.5 mg/dl 3 (30%)
Medication
Calcium antagonist 6 (60%)





Aspirin 4, Aspirin + Clopidogrel 2
CAD coronary artery disease, sCr serum creatinine, ACE inhibitor angiotensin
converting enzyme inhibitor, ARB angiotensin receptor blocker.
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enzyme-linked immunosorbent assay (ELISA) kit (Kainos
Laboratories Inc., Tokyo, Japan). Plasma VWF antigen was
measured using rabbit antihuman VWF polyclonal anti-
body (Dako, Kyoto, Japan). As an appearance of UL-VWF
in plasma has been demonstrated in patients with inad-
equate function or decreased level of ADAMTS13 [11,12],
plasma UL-VWF should be a marker to indicate the
imbalance between ADAMTS13 activity and VWF. But
UL-VWF assay, which is usually performed by electro-
phoresis analysis, is unfeasible for real-time diagnosis
or therapeutically monitoring. VWF functional assays
such as collagen-binding activity or ristocetin cofactor
activity are conventional to determine activity of VWF
multimer pattern; however, recent investigations indi-
cated the change in VWF antigen/ADAMTS13 ratio
rather than functional VWF assays could be relate to
thrombotic complications or organ dysfunction [8,14,15].
Thus, we adopted VWF antigen assay to determine VWF/
ADAMTS13 ratio. Both ADAMTS13 activity and VWF
antigen level are expressed as a percentage of normal con-
trol plasma.
Three cytokines including interleukin-6 (IL-6), IL-8/
CXCL8, and tumor necrosis factor α (TNF-α) were mea-
sured in duplicate by ELISA using commercially available
kit (Procarta cytokine Assay kit, Affymetrix Inc., CA,
USA). NGAL is a novel biomarker for AKI, which has
high sensitivity and specificity in detection of AKI [16].
NGAL was measured in duplicate using commercially
available ELISA kit (Human Lipocalon-2/NGAL ELISA
kit, R&D systems Inc., MN, USA).
Statistical analysis
Data were expressed as mean ± standard deviation unless
otherwise specified. A commercial statistical software
package (SigmaPlot 12; Systat Software Inc., CA, USA)
was used to analyze the data. Kruskal-Wallis H-test,
followed by Mann-Whitney U test with Bonferroni
correction, was used to compare the serial data in a
time course. Spearman correlation coefficient was calcu-
lated to determine the relationship between two parame-
ters where applicable. Two-tailed P value less than 0.05
was considered significant.
Results
Fourteen patients were included in the study. Four of 14
patients were excluded because of the lack of ADAMTS13
and VWF data. Patient characteristics are presented in
Table 1. Three patients had serum creatinine concentra-
tion more than 1.5 mg/dl, and two of them received the
medication of oral furosemide. Six patients received anti-
platelet therapy with aspirin (n = 4) or aspirin + clopidogrel
(n = 2), but these antiplatelet drugs were withdrawn
10–14days prior to the surgery. None of the patientsreceived anticoagulation therapy before the surgery.
Table 2 indicates results of preoperative coagulation and
fibrinolysis examination. Mean plasma concentrations of
fibrin/fibrinogen degradation products and D-dimer were
higher than normal level, which indicated increased plas-
min activity in preoperative period. Table 3 shows intraop-
erative and postoperative variables. Two patients received
furosemide during anesthesia due to transient de-
crease in urine output despite the appropriate fluid
therapy and hemodynamic parameters. Two patients
received a continuous infusion of dopamine due to per-
sistent hypotension (mean arterial blood pressure < 60
mmHg despite a total dose of phenylephrine 1 mg or
ephedrine 40 mg). No patients received either FFP or PC
during the study periods.
Figure 1 illustrates the changes in ADAMTS13 activity,
VWF antigen, VWF/ADAMTS13 ratio, and correlation
between ADAMTS13 activity and VWF antigen during
the study periods. Preoperative values of ADAMST13
were lower than the normal range in all patients.
ADAMTS13 showed a trend of decrease after the sur-
gery, but it was not statistically significant (Figure 1A).
VWF antigen increased significantly after the surgery
and maintained a supernormal level in the study period
(P < 0.01) (Figure 1B). Similar to the trend of VWF,
VWF/ADAMTS13 ratio presented a significant increase
after the surgery (P < 0.05) (Figure 1C). There was a
significant inverse correlation between ADAMTS13 and
VWF (R2 = 0.21, P < 0.05) (Figure 1D).
Table 2 Preoperative coagulation and fibrinolysis
examination
Mean ± SD Normal range
Hemoglobin 13.4 ± 1.2 (g/dl)
F, 12.0 ± 0.6 (g/dl) 12.5–15.0 g/dl
M, 13.7 ± 1.0 (g/dl)
13.5–17.0 g/dl
Platelet count 190 ± 98 (×103/μl) 160–350 × 103/μl
APTT 31.1 ± 1.5 (s) 23–36 s
PT-INR 1.07 ± 0.09 0.8–1.2
Fibrinogen 320 ± 47 (mg/dl) 160–350 mg/dl
FDP 6.7 ± 4.4 (μg/ml) <5 μg/ml
D-dimer 4.2 ± 3.4 (μg/ml) <1 μg/ml
F and M female and male, respectively, APTT activated prothrombin time,
PT-INR international normalized ratio/prothrombin time, FDP fibrin/fibrinogen
degradation products.
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IL-6 showed clinically and statistically significant increase
on 1POD (P < 0.01) and started to decrease towards
7POD (Figure 2A). The change in IL-8 showed a similar
trend to IL-6 although it remained within the normal
range. TNF-α showed a trend of increase towards 3POD
although it was not statistically significant. Both IL-6
and IL-8 had significant but weak correlations with
VWF/ADAMTS13 ratio (R2 = 0.12, P = 6.13 × 10−5 and
R2 = 0.04, P = 0.004, respectively), whereas there was no
correlation between TNF-α and VWF/ADAMTS13 ratio.Table 3 Intraoperative and postoperative variables
Variables Values
Intraoperative variables
Anesthesia time (min) 339 ± 62
Operation time (min) 236 ± 47
Aortic cross-clamp time (min) 58 ± 18
Blood loss (ml/kg) 20.1 ± 12.4
Urine (ml · kg−1 · hr−1) 3.3 ± 2.1
Infusion (ml · kg−1 · hr−1) 13.0 ± 5.1
Blood transfusion
Salvaged red blood cells (ml/kg) 8.9 ± 6.2








Hemodialysis in 30 days 0 (0%)
RBC irradiated packed red blood cells.Figure 3 illustrates the change in platelet count and the
correlation between VWF/ADAMTS13 ratio and platelet
count. Platelet count reached a nadir level on 1POD (not
significant) and showed a trend of increase towards
7POD. Platelet count demonstrated the trend of decrease
in coordination with the increase in VWF/ADAMTS13
ratio although it was not significant.
None of the patients had significant increase in Cr
postoperatively. Two patients, who had baseline Cr values
more than 1.5 mg/dl, received continuous infusion of car-
peritide and/or IV furosemide because their urine output
decreased less than 0.5 ml/kg/h continuing for several
hours on 3POD and 4POD, respectively. They received
intermittent IV furosemide for the next 3 days and main-
tained their urine output. Including these two patients,
none of the patients had persistent decrease in urine
output throughout the study periods. Hence, there was
no patient who was diagnosed as AKI according to AKIN
criteria.
Figure 4 illustrates the changes in plasma NGAL and
the correlation between VWF/ADAMTS13 ratio and
plasma NGAL. Plasma NGAL showed a trend to in-
crease after the surgery, which was significant on 3POD
(Figure 4A). The patients who received IV furosemide
had their maximum plasma NGAL values of 515 and
687 ng/ml on 3POD, respectively. The change in plasma
NGAL was correlated with VWF/ADAMTS13 ratio sig-
nificantly (R2 = 0.54, P = 7.76 × 10−5) (Figure 4B).
Discussion
The present study showed that the ratio of VWF/
ADAMTS13 increased significantly after the AAA sur-
gery, which may indicate increasing risk of prothrombotic
coagulation disorder. It also showed significant correlation
between inflammatory cytokines including IL-6 and IL-8
and VWF/ADAMTS13 ratio. Besides, NGAL value which
increased significantly after the surgery was correlated
with VWF/ADAMTS13 ratio. Collectively, the systemic
inflammation was associated with the increase in the ratio
of VWF/ADAMTS13 after the AAA surgery. Simultan-
eously, the increased VWF/ADAMTS13 ratio, indicating
increased risk of thrombosis, was associated with the
increase in plasma NGAL, one of the most sensitive
biomarkers for AKI [16].
Several investigations demonstrated perioperative change
in ADAMTS13 activity [17-19], whereas few studies have
been performed in major aortic surgery. The current study
demonstrated that patients with AAA had significantly
lower ADAMST13 activity than those undergoing cardiac
surgery in preoperative period [18,19]. Aortic aneurysm is
associated with change of coagulation system characterized
by increased thrombin generation and subsequent plasmin
production, which is proportional to the volume of intra-
luminal thrombus [20]. Since preoperative acceleration of
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Figure 1 Change in ADAMTS13 activity, VWF antigen, VWF/ADAMTS13 ratio, and correlation between ADAMTS13 and VWF. (A) Change
in ADAMTS13 activity. (B) Change in VWF antigen. (C) Change in VWF/ADAMTS13 ratio. (D) Correlation between ADAMTS13 activity and VWF
antigen. Solid lines represent mean values (SD), and dotted lines represent the native values. Shaded areas represent the normal ranges. *P < 0.01
vs. preoperative value. †P < 0.05 vs. preoperative value. Preop preoperative. ADAMTS13 activity was lower than the normal range through the
study period and showed a trend of decrease after the surgery. VWF antigen increased significantly after the surgery. There was a significant
increase in VWF/ADAMTS13 ratio after the surgery (P < 0.05). There was a significant inverse correlation between ADAMTS13 activity and VWF
antigen (P < 0.05).
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ation of ADAMTS13 by thrombin and/or plasmin could
partly explain the decreased level of ADAMTS13 activity
in patients with aortic aneurysm [21]. Several mechanisms
to account for the acute decline of ADAMTS13 have been
postulated such as accelerated consumption, suppressed
production or secretion [22], and increased VWF antigen.
Previous observations indicated the increase in plasma
VWF including UL-WVF, no matter which is endogenous
or exogenous, could induce decrease in ADAMTS13
activity [23,24]. Several interleukins are also postulated
to affect ADAMTS13 activity in patients with systemic
inflammation [25,26]. IL-6 showed a marked increase
after the surgery in correlation with VWF/ADAMTS13
ratio in the current study. In addition to the systemic
inflammatory response to surgical insults, the direct
release of IL-6 from aortic aneurysm might contributeto the increase in IL-6 after AAA surgery [27]. Increased
levels of inflammatory cytokines induced by surgical
insults could be one of the reasons for decreased
ADAMTS13 activity because inflammatory cytokines
including IL-6 and IL-8 enhances the release of UL-VWF
from endothelial cells and simultaneously inhibits cleavage
of UL-VWF by ADAMTS13 [26]. Although the mecha-
nisms that explain decrease in ADAMTS13 activity is
multifactorial, inverse or mirror image pattern between
VWF antigen level and ADAMTS13 activity observed in
the current was consistent with the results in the previous
studies [23,24].
The most important finding in the current study was
significant correlation between VWF/ADAMTS13 ratio
and plasma NGAL which is a novel biomarker for AKI.
In the setting of acute tubular injury, NGAL undergoes
rapid and profound upregulation with large increase in
A B
C
Figure 2 Change in IL-6, IL-8, and TNF-α. (A) Change in plasma IL-6. (B) Change in plasma IL-8. (C) Change in plasma TNF-α. Solid lines represent
mean values (SD), and dotted lines represent the native values. Shaded areas represent the normal ranges of the plasma cytokine concentration.
*P < 0.01 vs. preoperative value. †P < 0.05 vs. preoperative value. IL-6 and IL-8 increased significantly on 3POD and 7POD; however, IL-8 changed
within the normal range. There was no significant change in TNF-α.
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urine output decreased in two patients who had high
NGAL values after the surgery. And these two patients
received furosemide and/or carperitide therapy. As a
result, an early treatment according to clinical decisionBA
Figure 3 Change in platelet count and correlation between VWF/ADA
(B) Correlation between VWF/ADAMTS13 ratio and platelet count. Shaded
decreased towards 1POD (not significant) and showed a trend of recovery
coordination with the increase in VWF/ADAMTS13 ratio, although it was nomight obviate the development of AKI. Since one of the
clinical manifestations of TTP is kidney injury, which re-
sults from systemic TMA induced by severe deficiency of
ADAMTS13 with high VWF antigen/ADAMTS13 ratio
[30], the correlation between VWF/ADAMTS13 ratio andMTS13 ratio and platelet count. (A) Change in platelet count.
areas represent the normal range of platelet count. Platelet count
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Figure 4 Change in NGAL, and correlation between VWF/ADAMTS13 ration and NGAL. (A) Change in plasma NGAL. Solid line represents
mean values (SD), and dotted lines represent the native values. The dotted lines in red represent the values of the patients who received
furosemide therapy. Shaded area represents the normal range of plasma NGAL. †P < 0.05 vs. preoperative value. Plasma NGAL increased
significantly on 3POD. (B) Correlation between VWF/ADAMTS13 ration and plasma NGAL. There was a significant correlation between
VWF/ADAMTS13 ratio and plasma NGAL (P < 0.01).
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genesis of AKI after AAA surgery.
Recent data provide evidence that an altered ADAMTS13
activity and a subsequent shift in the multimeric pattern
of VWF may contribute to thrombocytopenia and micro-
circulatory failure due to TMA, which results in organ
dysfunction including AKI [8,9,31]. Several investigators
postulated that ADAMTS13 deficiency was associated
with AKI in patients with sepsis [7]. Martin et al. also
demonstrated that 50% of patients with severe sepsis suf-
fered from AKI in whom the median ADAMTS13 activity
was 43.2% [26]. This value is similar to the result in the
current study, whereas none of the patients was diagnosed
as AKI based on AKIN criteria. Such discrepancy between
sepsis and AAA patients might be attributed to the differ-
ence in severity and persistence of systemic inflammatory
response. Thrombocytopenia due to abnormal platelet ag-
gregation is usually recognized in patients with high
VWF/ADAMTS13 ratio. We found a trend of decrease in
platelet count with higher VWF/ADAMTS13 ratio in the
current study although it was not significant. Because
bleeding during the surgery also decreases platelet count,
it might be difficult to prove statistically significant correl-
ation between VWF/ADAMTS13 ratio and platelet count
in patients undergoing major aortic surgery. Furthermore,
decrease in platelet count due to bleeding during the sur-
gery might mask clinical manifestation or development of
TMA in spite of high VWF/ADAMTS13 ratio.
There are several limitations to interpret the data
herein. First, this study enrolled 14 patients and only 10
patients were accepted for the statistical analysis. We
could not exclude the contribution of this small sample
size on the detection of AKI. We estimated the incidence
of AKI after AAA surgery as 40% and calculated thesample size to show statistical significance as 24 cases
when we made the study protocol. However, we had to
cease the study after including 14 cases because the
elective open AAA surgery was almost replaced by
endovascular surgery in our institute. Second, we did
not directly measure UL-VWF level which is the most
important factor that induces abnormal platelet aggrega-
tion. An ideal method was to examine both VWF antigen
level and distribution of VWF multimers using electro-
phoresis analysis to prove existence of UL-VWF as shown
in previous studies [7,32]; however, electrophoresis analysis
is not always feasible in clinical diagnosis and therapeutic
monitoring. VWF activity assays are also useful to evaluate
contribution of VWF to platelet adhesion or aggregation.
Claus et al. investigated qualitative and quantitative var-
iations of VWF and ADAMTS13 in patients with in-
flammation of varying severity, but they could not find a
significant correlation between VWF activity and TMA
or severity of organ dysfunction [8]. They concluded
that VWF antigen/ADAMTS13 ratio could be a helpful
parameter to identify patients with high risk of TMA or
organ dysfunction due to systemic inflammation. Recent
investigations also indicated that high VWF antigen level
accompanied by decreased ADAMTS13 activity (high
VWF antigen/ADAMTS13 ratio) could be a good par-
ameter to evaluate prothrombotic properties or severity
of diseases [15,33,34]. Third, the current study could
not demonstrate the direct link between high VWF/
ADAMTS13 ratio and TMA in the kidney. We did not
examine histological change in the kidney because it is
too invasive in the clinical setting although Bockmeyer
et al. demonstrated that TMA induced by the ADAMTS13
deficiency was associated with the development of tubular
injury and consequent AKI in a porcine model [35].
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The current study demonstrated that increased VWF/
ADAMTS13 ratio was associated with the increase in IL-6
which reflects systemic inflammation in AAA surgery.
Furthermore, there was significant correlation between
VWF/ADAMTS13 ratio and NGAL which is a sensitive
early phase biomarker reflecting renal tubular injury. As
the association between high VWF/ADAMTS13 and TMA
has been indicated, prothrombotic coagulation abnormality
due to systemic inflammation might be one of the contri-
butions to the development of AKI after AAA surgery.
Further study is needed to confirm our findings.
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